Skip to content

HUVESEARCH: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

HUVESEARCH

BE 0822.612.359
NACE 21.201, Manufacture of basic pharmaceutical products and pharmaceutical preparations
financial year 2023 against 2024filed annual accounts (NBB)
Net result for the year
€12,298
2023 · -€1,446+€13,744
Equity
€61,857
2023 · €65,508-€3,651
Cash
€45,578
2023 · €20,616+€24,961
Balance sheet total
€112,893
2023 · €103,338+€9,555

Largest movements

2023 to 2024
Assets
  • Cash +€24,961

    up €24,961 (+121.1%), from €20,616 to €45,578

    mainly Other debts (+€15,152) and Net result for the year (+€12,298)

  • Receivables within one year -€10,843

    down €10,843 (-54.6%), from €19,875 to €9,032

    of which Trade receivables: -€8,102

  • Tangible fixed assets -€4,012

    down €4,012 (-38.9%), from €10,304 to €6,292

    of which Furniture and vehicles: -€2,367

Equity and liabilities
  • Other debts +€15,152

    new in 2024: €15,152

  • Trade debts -€6,360

    down €6,360 (-96.0%), from €6,625 to €264

  • Reserves -€5,097

    down €5,097 (-9.8%), from €51,803 to €46,705

    of which Distributable reserves: -€5,097

  • Tax, wage and social debts +€4,392

    up €4,392 (+950.5%), from €462 to €4,855

  • Profit (loss) carried forward +€1,446

    no longer reported in 2024 (was -€1,446)

Income statement
  • Gross operating margin +€18,905

    up €18,905 (+328.1%), from €5,762 to €24,666

  • Taxes +€6,757

    up €6,757 (+2253.7%), from €300 to €7,057

  • Financial charges -€1,502

    down €1,502 (-67.1%), from €2,239 to €737

From the 2023 result to the 2024 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2023 -€1,446
Gross operating margin +€18,905
Depreciation +€167
Other operating charges -€7
Financial income -€65
Financial charges +€1,502
Taxes -€6,757
Result 2024 €12,298

Cash bridge derived

cash 2023 to 2024

Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€40,910
Investment €0
Financing -€15,949
Cash 2023 €20,616
Net result for the year +€12,298
Depreciation +€4,012
Stocks and contracts +€755
Receivables within one year +€10,843
Deferred charges and accrued income -€203
Trade debts -€6,360
Tax, wage and social debts +€4,392
Other debts +€15,152
Accrued charges and deferred income +€22
Contributions, distributions and other -€15,949
Cash 2024 €45,578
Every line side by side 50 lines
Line Code 2023 2024 Change %
Total assets 20/58 €103,338 €112,893 +€9,555 +9.2%
Formation expenses 20 - €0 =
Fixed assets 21/28 €12,044 €8,032 -€4,012 -33.3%
Intangible fixed assets 21 - €0 =
Tangible fixed assets 22/27 €10,304 €6,292 -€4,012 -38.9%
Plant, machinery and equipment 23 €4,396 €2,752 -€1,645 -37.4%
Furniture and vehicles 24 €5,907 €3,540 -€2,367 -40.1%
Financial fixed assets 28 €1,740 €1,740 = 0.0%
Current assets 29/58 €91,294 €104,860 +€13,566 +14.9%
Stocks and contracts in progress 3 €50,627 €49,872 -€755 -1.5%
Stocks 30/36 €50,627 €49,872 -€755 -1.5%
Amounts receivable within one year 40/41 €19,875 €9,032 -€10,843 -54.6%
Trade receivables 40 €14,045 €5,943 -€8,102 -57.7%
Other amounts receivable 41 €5,830 €3,089 -€2,741 -47.0%
Cash at bank and in hand 54/58 €20,616 €45,578 +€24,961 +121.1%
Deferred charges and accrued income 490/1 €175 €378 +€203 +115.7%
Total equity and liabilities 10/49 €103,338 €112,893 +€9,555 +9.2%
Equity 10/15 €65,508 €61,857 -€3,651 -5.6%
Contributions 10/11 €15,152 €15,152 = 0.0%
Contributions outside capital 11 €15,152 - -€15,152
Other 1109/19 €15,152 - -€15,152
Reserves 13 €51,803 €46,705 -€5,097 -9.8%
Non-distributable reserves 130/1 €1,860 €1,860 = 0.0%
Reserves not available under the articles 1311 €1,860 €1,860 = 0.0%
Tax-exempt reserves 132 €13,045 €13,045 = 0.0%
Distributable reserves 133 €36,897 €31,800 -€5,097 -13.8%
Profit (loss) carried forward 14 -€1,446 - +€1,446
Provisions and deferred taxes 16 €30,000 €30,000 = 0.0%
Provisions for liabilities and charges 160/5 €30,000 €30,000 = 0.0%
Other liabilities and charges 164/5 €30,000 €30,000 = 0.0%
Amounts payable 17/49 €7,829 €21,035 +€13,206 +168.7%
Amounts payable within one year 42/48 €7,087 €20,270 +€13,184 +186.0%
Trade debts 44 €6,625 €264 -€6,360 -96.0%
Suppliers 440/4 €6,625 €264 -€6,360 -96.0%
Taxes, remuneration and social security 45 €462 €4,855 +€4,392 +950.5%
Taxes 450/3 €462 €4,855 +€4,392 +950.5%
Other amounts payable 47/48 - €15,152 +€15,152
Accrued charges and deferred income 492/3 €743 €765 +€22 +3.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €4,179 €4,012 -€167 -4.0%
Other operating charges 640/8 €643 €650 +€7 +1.1%
Gross operating margin 9900 €5,762 €24,666 +€18,905 +328.1%
Operating profit (loss) 9901 €940 €20,005 +€19,065 +2028.8%
Financial income 75/76B €153 €88 -€65 -42.6%
Recurring financial income 75 €153 €88 -€65 -42.6%
Financial charges 65/66B €2,239 €737 -€1,502 -67.1%
Recurring financial charges 65 €2,239 €737 -€1,502 -67.1%
Profit (loss) for the period before taxes 9903 -€1,146 €19,355 +€20,501
Income taxes 67/77 €300 €7,057 +€6,757 +2253.7%
Profit (loss) for the period 9904 -€1,446 €12,298 +€13,744
Profit (loss) for the period to be appropriated 9905 -€1,446 €12,298 +€13,744

Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 12 October 2026 via checked.be.